bpc-157 pharmacokinetics half-life human and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded The Stable Gastric Pentadecapeptide BPC

BPC-157 is a 15-residue, 1419.53 g/mol pentadecapeptide whose mechanistic literature centres on local angiogenic signalling, Hsieh and colleagues (J Mol Med, 2017) reported upregulation and internalisation of VEGFR2 in human endothelial cells, and Chang and colleagues (J Appl Physiol, 2011) reported increased FAK and paxillin phosphorylation with greater outgrowth and migration in cultured rat tendon fibroblasts

Linebarger about finding out if this is right for you

Soft tissue (tendon, ligament) responds slower than mucosal tissue (gut)

the 6-10 week figure is a practitioner-derived research convention, not a clinical endpoint